400-6699-1171000

分析测试百科网 认证会员,请放心拨打!

首页> 产品展示> Coagulation factor VII/F7, Human, 重组蛋白 (His) TMPY-02014
普通会员

诚信认证:

工商注册信息已核实!

快速导航
品牌
其他生物化学试剂

Coagulation factor VII/F7, Human, 重组蛋白 (His) TMPY-02014

英文名称:Coagulation factor VII/F7 Protein, Human, Recombinant (His)
品牌 厂商性质 产地 货期
TargetMol 生产商 美国 现货

性能特点

生化试剂,可用于动物细胞实验

在线咨询 询底价
AI问答
配套的仪器设备? 可以搭配的相关耗材试剂?
产品参数
规格 价格 操作
20 μg ¥3,820.00 询底价
50 μg ¥5,750.00 询底价
产品介绍

Product Introduction
Bioactivity


英文名: Coagulation factor VII/F7 Protein, Human, Recombinant (His)

描述: Coagulation factor VII, also known as Serum prothrombin conversion accelerator, Factor VII, F7 and FVII, is a member of the peptidase S1 family. Factor VII is one of the central proteins in the coagulation cascade. It is an enzyme of the serine protease class, and Factor VII (FVII) deficiency is the most frequent among rare congenital bleeding disorders. Factor VII contains two EGF-like domains, one Gla (gamma-carboxy-glutamate) domain and one peptidase S1 domain. The main role of factor VII is to initiate the process of coagulation in conjunction with tissue factor (TF). Tissue factor is found on the outside of blood vessels, normally not exposed to the blood stream. The action of the Factor VII is impeded by tissue factor pathway inhibitor (TFPI), which is released almost immediately after initiation of coagulation. Factor VII is vitamin K dependent and is produced in the liver. Upon vessel injury, tissue factor is exposed to the blood and circulating Factor VII. Once bound to TF, FVII is activated to FVIIa by different proteases, among which are thrombin (factor IIa), factor Xa, IXa, XIIa, and the FVIIa-TF complex itself. Recombinant activated factor VII (rFVIIa) is a haemostatic agent, which was originally developed for the treatment of haemophilia patients with inhibitors against factor FVIII or FIX. FVIIa binds specifically to endothelial protein C receptor (EPCR), a known cellular receptor for protein C and activated protein C, on the endothelium. rFVIIa is a novel hemostatic agent, originally developed for the treatment of hemorrhage in hemophiliacs with inhibitors, which has been successfully used recently in an increasing number of nonhemophilic bleeding conditions.

存储条件: Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month

关键字: serum prothrombin conversion accelerator

Coagulation factor VII/F7, Human, 重组蛋白 (His) TMPY-02014信息由TargetMol中国为您提供,如您想了解更多关于Coagulation factor VII/F7, Human, 重组蛋白 (His) TMPY-02014报价、型号、参数等信息,欢迎来电或留言咨询。

注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途

店铺推荐
  • 品牌:TargetMol
    蛋白酶抑制剂 Cocktail (EDTA-Free, 100× in DMSO) C0001

    蛋白酶抑制剂 Cocktail (EDTA-Free, 100× in DMSO) C0001

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail I (100× ddH2O) C0002

    磷酸酶抑制剂 Cocktail I (100× ddH2O) C0002

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail II (100× DMSO) C0003

    磷酸酶抑制剂 Cocktail II (100× DMSO) C0003

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail III (2 Tubes, 100x) C0004

    磷酸酶抑制剂 Cocktail III (2 Tubes, 100x) C0004

    询价
  • 品牌:TargetMol
    Cell Counting Kit-8 (CCK-8) C0005

    Cell Counting Kit-8 (CCK-8) C0005

    询价
  • 品牌:TargetMol
    SYBR Green qPCR Master Mix (No ROX) C0006

    SYBR Green qPCR Master Mix (No ROX) C0006

    询价